Taylor Frigon Capital Management LLC cut its stake in Apyx Medical Co. (NASDAQ:APYX – Free Report) by 8.6% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 545,748 shares of the company’s stock after selling 51,128 shares during the period. Taylor Frigon Capital Management LLC owned 1.45% of Apyx Medical worth $862,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors also recently bought and sold shares of the company. Kingsview Wealth Management LLC boosted its stake in Apyx Medical by 8.7% in the 4th quarter. Kingsview Wealth Management LLC now owns 135,245 shares of the company’s stock worth $214,000 after purchasing an additional 10,800 shares in the last quarter. Private Advisor Group LLC boosted its stake in Apyx Medical by 3.9% in the 3rd quarter. Private Advisor Group LLC now owns 322,321 shares of the company’s stock worth $400,000 after purchasing an additional 12,180 shares in the last quarter. Finally, Royce & Associates LP lifted its stake in Apyx Medical by 3.4% during the 3rd quarter. Royce & Associates LP now owns 2,582,490 shares of the company’s stock valued at $3,202,000 after acquiring an additional 85,267 shares during the period. 55.33% of the stock is currently owned by institutional investors and hedge funds.
Apyx Medical Stock Performance
Shares of NASDAQ APYX opened at $1.43 on Thursday. The company has a current ratio of 5.46, a quick ratio of 4.52 and a debt-to-equity ratio of 3.03. Apyx Medical Co. has a 12 month low of $0.97 and a 12 month high of $2.30. The company has a 50 day simple moving average of $1.51 and a two-hundred day simple moving average of $1.39. The stock has a market cap of $53.83 million, a price-to-earnings ratio of -1.72 and a beta of 1.25.
About Apyx Medical
Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.
Further Reading
- Five stocks we like better than Apyx Medical
- 5 discounted opportunities for dividend growth investors
- Buffett’s on the Sidelines – Should You Follow?
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- Using the MarketBeat Dividend Yield Calculator
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.